RxDoctor Payments Data

Michel Makaroun, MD

Vascular Surgery · Pittsburgh, PANPI 1689648792

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $122,014 of the $142,989 with a category attached, or 85.3%. W. L. Gore & Associates, Inc. accounts for 89.9% of it on its own, with 6 other manufacturers making up the rest. Among vascular surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,989in general payments, 2019–2025

Across 170 payments — averaging $841.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$129K
  • Kowa Research Institute, Inc.$7K
  • Medtronic$7K
  • Penumbra, Inc.$125
  • Cook Medical LLC$86
  • Davol Inc.$76
  • plus $70 from 1 others
$97,620in research payments, 2019–2025

Across 31 payments — averaging $3149.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$84K
  • Endologix LLC$14K

What the payments were for

  • Consulting fees$122,01485%
  • Speaking & faculty fees$3750%
  • Grants$170%
  • Travel & lodging$12,9039%
  • Food & beverage$7,6055%
  • Education$760%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,989 in reported general payments places this provider in the 95th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$64,216
Medicare patients
220
Services billed
335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban13$9,080
EliquisApixaban13$8,985
BrilintaTicagrelor12$6,095
ClopidogrelClopidogrel Bisulfate38$492
Atorvastatin Calcium18$218
Prednisone24$22

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →